View all services

Mergers & Acquisitions

CM Life Sciences II Acquires SomaLogic, Inc.

SomaLogic, a privately-owned protein biomarker discovery and diagnostics company, was acquired by CM Life Sciences II (NASDAQ: CMII), a special purpose acquisition company, for $651 million. 

Morrow Sodali acted as the proxy solicitor for the target in this transaction.

Find more information here.

Mergers and Acquisitions
For further inquiries
Contact us
Contact us

Please complete this form to be contacted by a Morrow Sodali representative.